Literature DB >> 19064565

Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.

Karen A Pooley1, Caroline Baynes, Kristy E Driver, Jonathan Tyrer, Elizabeth M Azzato, Paul D P Pharoah, Douglas F Easton, Bruce A J Ponder, Alison M Dunning.   

Abstract

The proteins involved in homologous recombination are instrumental in the error-free repair of dsDNA breakages, and common germ-line variations in these genes are, therefore, potential candidates for involvement in breast cancer development and progression. We carried out a search for common, low-penetrance susceptibility alleles by tagging the common variation in 13 genes in this pathway in a two-stage case-control study. We genotyped 100 single-nucleotide polymorphisms (SNP), tagging the 655 common SNPs in these genes, in up to 4,470 cases and 4,560 controls from the SEARCH study. None of these tagging SNPs was associated with breast cancer risk, with the exception of XRCC2 rs3218536, R188H, which showed some evidence of a protective association for the rare allele [per allele odds ratio, 0.89; 95% confidence intervals (95% CI), 0.80-0.99; P trend = 0.03]. Further analyses showed that this effect was confined to a risk of progesterone receptor positive tumors (per rare allele odds ratio, 0.78; 95% CI, 0.66-0.91; P trend = 0.002). Several other SNPs also showed receptor status-specific susceptibility and evidence of roles in long-term survival, with the rare allele of BRIP1 rs2191249 showing evidence of association with a poorer prognosis (hazard ratio per minor allele, 1.20; 95% CI, 1.07-1.36; P trend = 0.002). In summary, there was little evidence of breast cancer susceptibility with any of the SNPs studied, but larger studies would be needed to confirm subgroup effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064565     DOI: 10.1158/1055-9965.EPI-08-0594

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  17 in total

1.  VARS2 V552V variant as prognostic marker in patients with early breast cancer.

Authors:  Yee Soo Chae; Soo Jung Lee; Joon Ho Moon; Byung Woog Kang; Jong Gwang Kim; Sang Kyun Sohn; Jin Hyang Jung; Ho Yong Park; Ji Young Park; Hye Jung Kim; Sang-Woo Lee
Journal:  Med Oncol       Date:  2010-05-26       Impact factor: 3.064

2.  Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects.

Authors:  Bin Kong; Zhi-Dong Lv; Li Chen; Ruo-Wu Shen; Li-Ying Jin; Zhao-Chuan Yang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  The effect of polymorphism in DNA repair genes RAD51 and XRCC2 in colorectal cancer in Turkish population.

Authors:  Suleyman Cetinkunar; Ilhami Gok; Ruchan Bahadir Celep; Dogan Ilhan; Hasan Erdem; Bulent Caglar Bilgin; Recep Aktimur
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  The Arg188His polymorphism in the XRCC2 gene and the risk of cancer.

Authors:  Yonggang Zhang; Haichuan Wang; Yuanling Peng; Yuqi Liu; Tianyuan Xiong; Pei Xue; Liang Du
Journal:  Tumour Biol       Date:  2014-01-12

5.  No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.

Authors:  Karen A Pooley; Jonathan Tyrer; Mitul Shah; Kristy E Driver; Jean Leyland; Judith Brown; Tina Audley; Lesley McGuffog; Bruce A J Ponder; Paul D P Pharoah; Douglas F Easton; Alison M Dunning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

6.  Telomere length in prospective and retrospective cancer case-control studies.

Authors:  Karen A Pooley; Manjinder S Sandhu; Jonathan Tyrer; Mitul Shah; Kristy E Driver; Robert N Luben; Sheila A Bingham; Bruce A J Ponder; Paul D P Pharoah; Kay-Tee Khaw; Douglas F Easton; Alison M Dunning
Journal:  Cancer Res       Date:  2010-04-15       Impact factor: 12.701

7.  Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis.

Authors:  Karen Curtin; Wei-Yu Lin; Rina George; Mark Katory; Jennifer Shorto; Lisa A Cannon-Albright; Gillian Smith; D Timothy Bishop; Angela Cox; Nicola J Camp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08-18       Impact factor: 4.254

8.  A role for XRCC2 gene polymorphisms in breast cancer risk and survival.

Authors:  Wei-Yu Lin; Nicola J Camp; Lisa A Cannon-Albright; Kristina Allen-Brady; Sabapathy Balasubramanian; Malcolm W R Reed; John L Hopper; Carmel Apicella; Graham G Giles; Melissa C Southey; Roger L Milne; Jose I Arias-Pérez; Primitiva Menéndez-Rodríguez; Javier Benítez; Magdalena Grundmann; Natalia Dubrowinskaja; Tjoung-Won Park-Simon; Thilo Dörk; Montserrat Garcia-Closas; Jonine Figueroa; Mark Sherman; Jolanta Lissowska; Douglas F Easton; Alison M Dunning; Preetha Rajaraman; Alice J Sigurdson; Michele M Doody; Martha S Linet; Paul D Pharoah; Marjanka K Schmidt; Angela Cox
Journal:  J Med Genet       Date:  2011-05-31       Impact factor: 6.318

9.  A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.

Authors:  Satoru Yokoyama; Susan L Woods; Glen M Boyle; Lauren G Aoude; Stuart MacGregor; Victoria Zismann; Michael Gartside; Anne E Cust; Rizwan Haq; Mark Harland; John C Taylor; David L Duffy; Kelly Holohan; Ken Dutton-Regester; Jane M Palmer; Vanessa Bonazzi; Mitchell S Stark; Judith Symmons; Matthew H Law; Christopher Schmidt; Cathy Lanagan; Linda O'Connor; Elizabeth A Holland; Helen Schmid; Judith A Maskiell; Jodie Jetann; Megan Ferguson; Mark A Jenkins; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; David C Whiteman; Paul D Pharoah; Douglas F Easton; Alison M Dunning; Julia A Newton-Bishop; Grant W Montgomery; Nicholas G Martin; Graham J Mann; D Timothy Bishop; Hensin Tsao; Jeffrey M Trent; David E Fisher; Nicholas K Hayward; Kevin M Brown
Journal:  Nature       Date:  2011-11-13       Impact factor: 49.962

10.  The association of DNA Repair with breast cancer risk in women. A comparative observational study.

Authors:  Jaime Matta; Miguel Echenique; Esperanza Negron; Luisa Morales; Wanda Vargas; Felipe Sánchez Gaetan; Eduardo Ramírez Lizardi; Aníbal Torres; Jose Ortiz Rosado; Guillermo Bolaños; Juan González Cruz; Joaquín Laboy; Ricardo Barnes; Santos Santiago Medina; Angel Romero; Rosendo Martinez; Julie Dutil; Erick Suarez; Carolina Alvarez-Garriga; Manuel Bayona
Journal:  BMC Cancer       Date:  2012-10-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.